Page last updated: 2024-10-25

decamethonium and Neuromuscular Diseases

decamethonium has been researched along with Neuromuscular Diseases in 1 studies

decamethonium: RN given refers to parent cpd
decamethonium : A quaternary ammonium ion that is a depolarising muscle relaxant whose structure comprises a decane-1,10-diamine core in which each amino group carries three methyl substituents.

Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
THESLEFT, S1

Other Studies

1 other study available for decamethonium and Neuromuscular Diseases

ArticleYear
The mode of neuromuscular block caused by acetylcholine, nicotine, decamethonium and succinylcholine.
    Acta physiologica Scandinavica, 1955, Oct-27, Volume: 34, Issue:2-3

    Topics: Acetylcholine; Decamethonium Compounds; Humans; Muscle Relaxants, Central; Neuromuscular Blockade; N

1955